Literature DB >> 24247115

Update on etio and immunopathogenesis of Kawasaki disease.

Kei Takahashi1, Toshiaki Oharaseki, Yuki Yokouchi.   

Abstract

PURPOSE OF REVIEW: This review first discusses the pathogenesis of Kawasaki disease based on the results of recently performed studies aimed at identifying Kawasaki disease-susceptibility genes and the results of analyses of the immune system. Following that, we discuss the findings generated using a murine Kawasaki disease arteritis model and speculate regarding the mechanism of Kawasaki disease onset based on immune function aberrations seen in that model. RECENT
FINDINGS: Recent advances in gene analysis studies of Kawasaki disease are contributing not only to prediction of disease susceptibility but also to improving our understanding of the pathogenesis of Kawasaki disease and development of new improved therapies. In addition, Th17/Treg imbalance is observed in patients with acute-phase Kawasaki disease. Th17/Treg imbalance may be an important factor causing disturbed immunological function. IL-17 induced by Th17 cells have proinflammatory properties and act on inflammatory cells, thereby inducing expression of cytokines and chemokines and resulting in tissue inflammation.
SUMMARY: Kawasaki disease vasculitis may be triggered by aberrant activation of inflammatory cytokines mediated by IL-17 that is produced by Th17 cells that have been activated by some infectious agent(s).

Entities:  

Mesh:

Year:  2014        PMID: 24247115     DOI: 10.1097/BOR.0000000000000010

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  27 in total

Review 1.  2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease.

Authors:  Frank Zhu; Jocelyn Y Ang
Journal:  Curr Infect Dis Rep       Date:  2021-02-06       Impact factor: 3.725

2. 

Authors:  Teeranai Sakulchit; Susanne M Benseler; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

Review 3.  Acetylsalicylic acid for children with Kawasaki disease.

Authors:  Teeranai Sakulchit; Susanne M Benseler; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

4.  Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.

Authors:  Miyu Tajima; Yusuke Shiozawa; Jiro Kagawa
Journal:  Pediatr Cardiol       Date:  2015-03-10       Impact factor: 1.655

Review 5.  The Roles of Genetic Factors in Kawasaki Disease: A Systematic Review and Meta-analysis of Genetic Association Studies.

Authors:  Xiaochuan Xie; Xiaohan Shi; Meilin Liu
Journal:  Pediatr Cardiol       Date:  2017-11-02       Impact factor: 1.655

Review 6.  Kawasaki disease: etiopathogenesis and novel treatment strategies.

Authors:  Shreya Agarwal; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-09-13       Impact factor: 4.473

7.  Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.

Authors:  Ana Esteve-Sole; Jordi Anton; Rosa Maria Pino-Ramirez; Judith Sanchez-Manubens; Victoria Fumadó; Claudia Fortuny; María Rios-Barnes; Joan Sanchez-de-Toledo; Mónica Girona-Alarcón; Juan Manuel Mosquera; Silvia Ricart; Cristian Launes; Mariona Fernández de Sevilla; Cristina Jou; Carmen Muñoz-Almagro; Eva González-Roca; Andrea Vergara; Jorge Carrillo; Manel Juan; Daniel Cuadras; Antoni Noguera-Julian; Iolanda Jordan; Laia Alsina
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 8.  The Immunogenetics of Vasculitis.

Authors:  Fotini B Karassa; Eleftherios Pelechas; Georgios Zouzos
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

9.  Increased Risk of Kawasaki Disease in Infants Born of Mothers With Immune Disorders.

Authors:  Hsiao-Wen Chu; Chien-Heng Lin; Ming-Chih Lin; Ya-Chi Hsu
Journal:  Front Pediatr       Date:  2021-05-14       Impact factor: 3.418

10.  Attenuation of Myeloid-Specific TGFβ Signaling Induces Inflammatory Cerebrovascular Disease and Stroke.

Authors:  M Christine Hollander; Lawrence L Latour; Dan Yang; Hiroki Ishii; Zhiguang Xiao; Yongfen Min; Abhik Ray-Choudhury; Jeeva Munasinghe; Anand S Merchant; P Charles Lin; John Hallenbeck; Manfred Boehm; Li Yang
Journal:  Circ Res       Date:  2017-10-19       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.